Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharma…
| Periodo | 2026-10 | 2012-02 | 2010-02 | 2009-11 |
|---|---|---|---|---|
| Real | — | $-0.01 | $0.01 | $0.04 |
| Estimado | — | — | $0.02 | — |
| Sorpresa | — | — | -50.0% | — |
| Métrica | FAE.MC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.4% | — |
| Operating Margin | — | -34.4% | — |
| Net Margin | 22.6% | -32.5% | +55.0% |
| FCF Margin | 16.5% | -12.6% | +29.1% |
| ROE | 15.3% | -39.2% | +54.5% |
| ROA | 13.1% | -30.9% | +44.0% |
| Current Ratio | 3.23 | 2.73 | +0.50 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY24 | FY23 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 13.1% | — |
| ✓Flujo de caja operativo positivo | €115M | €101M |
| ✓Rentabilidad sobre activos al alza | 13.1% | 11.8% |
| ✓Caja operativa/activos supera al ROA | 13.5% | ROA 13.1% |
| –Menos deuda a largo plazo | — | — |
| ✗Mejor liquidez (ratio corriente) | 3.23 | 3.33 |
| ✗Sin aumentar el nº de acciones | — | — |
| –Margen bruto al alza | — | — |
| ✗Rotación de activos al alza | 0.58 | 0.58 |
| Calidad del negocio | FY24 |
|---|---|
| ✓Margen FCF > 10 % | 16.5% |
| ✓Ventas > 5 %/año (3 años) | 7.4% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 6.8% |
FAES FARMA SA cotiza a 4.74 EUR y tiene una capitalización bursátil de €1.5B. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Salud